The amyloid state and its association with protein misfolding diseases.
The DOI matches its Crossref record; 187 of the 187 references it cites were found in a registry or an index.
Abstract
The phenomenon of protein aggregation and amyloid formation has become the subject of rapidly increasing research activities across a wide range of scientific disciplines. Such activities have been stimulated by the association of amyloid deposition with a range of debilitating medical disorders, from Alzheimer's disease to type II diabetes, many of which are major threats to human health and welfare in the modern world. It has become clear, however, that the ability to form the amyloid state is more general than previously imagined, and that its study can provide unique insights into the nature of the functional forms of peptides and proteins, as well as understanding the means by which protein homeostasis can be maintained and protein metastasis avoided.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Disruption of NCC is a well-established effect of aging across species and is directly associated with other diseases, including amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).”
From Chemically induced reprogramming to reverse cellular aging (2023) · cites this paper as [63]
In the citing paper
“As a result, aggregation is enhanced for a set of proteins that have certain properties resembling disease-associated proteins with structural disorder (Knowles et al., 2014).”
From Widespread Proteome Remodeling and Aggregation in Aging C. elegans (2015) · cites this paper as Knowles et al., 2014
In the citing paper
“Therefore, IDPs have also become the focus of studies of molecular mechanisms of amyloid aggregation, characterized by conformational transitions from intrinsic disorder in the soluble monomeric/oligomeric form to ordered self-assembled amyloid fibrils of the same proteins.262–263”
From Protein Ensembles: How Does Nature Harness Thermodynamic Fluctuations for Life? The Diverse Functional Roles of Conformational Ensembles in the Cell (2016) · cites this paper as [262]
Citations
Cites
1 retracted
RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory
Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., & Ashe, K. H. (2006) · Nature · doi:10.1038/nature04533 · Cited by 2,769
RetractedBerman, H. M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.235 · Cited by 40,196
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y.-J., Jiang, Q., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,304
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Principles that Govern the Folding of Protein Chains
Anfinsen, C. B. (1973) · Science · doi:10.1126/science.181.4096.223 · Cited by 7,096
Autophagy fights disease through cellular self-digestion
Mizushima, N., Levine, B., Cuervo, A. M., & Klionsky, D. J. (2008) · Nature · doi:10.1038/nature06639 · Cited by 6,452
Cited by
Items 201–300 of 1,007
Poulson, B. G., Szczepski, K., Lachowicz, J. I., Jaremko, Ł., Emwas, A.-H. M., & Jaremko, M. (2020) · RSC Advances · doi:10.1039/c9ra09350h · Cited by 109
BODIPY-Based Fluorescent Probes for Sensing Protein Surface-Hydrophobicity
Dorh, N., Zhu, S., Dhungana, K. B., Pati, R., Luo, F., Liu, H., & Tiwari, A. (2015) · Scientific Reports · doi:10.1038/srep18337 · Cited by 103
Ruggeri, F. S., Benedetti, F., Knowles, T. P. J., Lashuel, H. A., Sekatskii, S. K., & Dietler, G. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1721220115 · Cited by 102
Self-citationMetal Binding of Alzheimer’s Amyloid-β and Its Effect on Peptide Self-Assembly
Abelein, A. (2023) · Accounts of Chemical Research · doi:10.1021/acs.accounts.3c00370 · Cited by 109
Highly Disordered Amyloid-β Monomer Probed by Single-Molecule FRET and MD Simulation
Meng, F., Bellaiche, M. M. J., Kim, J. Y., Zerze, G. H., Best, R. B., & Chung, H. S. (2018) · Biophysical Journal · doi:10.1016/j.bpj.2017.12.025 · Cited by 108
Shrestha, U. R., Juneja, P., Zhang, Q., Gurumoorthy, V., Borreguero, J. M., Urban, V., Cheng, X., Pingali, S. V., Smith, J. C., O’Neill, H. M., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1907251116 · Cited by 107
Energy landscapes of functional proteins are inherently risky
Gershenson, A., Gierasch, L. M., Pastore, A., & Radford, S. E. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1670 · Cited by 99
Ciryam, P., Lambert-Smith, I. A., Bean, D. M., Freer, R., Cid, F., Tartaglia, G. G., Saunders, D. N., Wilson, M. R., Oliver, S. G., Morimoto, R. I., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1613854114 · Cited by 111
Self-citationPhysical determinants of the self-replication of protein fibrils
Šarić, A., Buell, A. K., Meisl, G., Michaels, T. C. T., Dobson, C. M., Linse, S. S., Knowles, T. P. J., & Frenkel, D. (2016) · Nature Physics · doi:10.1038/nphys3828 · Cited by 105
Self-citationDNA repair in the trinucleotide repeat disorders
Jones, L., Houlden, H., & Tabrizi, S. J. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)30350-7 · Cited by 106
Aβ plaque-selective NIR fluorescence probe to differentiate Alzheimer's disease from tauopathies
Rajasekhar, K., Narayanaswamy, N., Murugan, N. A., Viccaro, K., Lee, H.-G., Shah, K., & Govindaraju, T. (2017) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2017.06.030 · Cited by 97
“…accretion of Aβ, α-Syn, tau, IAPP, polyglutamine and superoxide dismutase are considered as causative factors for Alzheimer’s, tauopathies, diabetes Huntington’s, Parkinson’s and amyotrophic lateral sclerosis diseases, respectively (Knowles et al., 2014; Soto et al., 2003; Rajasekhar et al., 2015).”
BackgroundOrganization of Amino Acids into Layered Supramolecular Secondary Structures
Bera, S., Mondal, S., Rencus‐Lazar, S., & Gazit, E. (2018) · Accounts of Chemical Research · doi:10.1021/acs.accounts.8b00131 · Cited by 100
Antioxidant Berberine-Derivative Inhibits Multifaceted Amyloid Toxicity
Rajasekhar, K., Samanta, S., Bagoband, V., Murugan, N. A., & Govindaraju, T. (2020) · iScience · doi:10.1016/j.isci.2020.101005 · Cited by 99
“Alzheimer’s disease (AD) is the most prevalent neurodegenerative disorder and accounts for more than 70% of all dementia (Knowles et al., 2014; Selkoe and Hardy, 2016).”
BackgroundGonzález, J. F., Alcántara, A. R., Doadrio, A. L., & Sánchez-Montero, J. M. (2019) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2019.1623201 · Cited by 98
Hayes, M. H., Peuchen, E. H., Dovichi, N. J., & Weeks, D. L. (2018) · eLife · doi:10.7554/elife.35224 · Cited by 98
Chaperones in Neurodegeneration
Lindberg, I., Shorter, J., Wiseman, R. L., Chiti, F., Dickey, C. A., & McLean, P. J. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.2600-15.2015 · Cited by 93
Freer, R., Sormanni, P., Vecchi, G., Ciryam, P., Dobson, C. M., & Vendruscolo, M. (2016) · Science Advances · doi:10.1126/sciadv.1600947 · Cited by 100
Self-citationJi, W., Yuan, C., Chakraborty, P., Makam, P., Bera, S., Rencus‐Lazar, S., Li, J., Yan, X., & Gazit, E. (2020) · ACS Nano · doi:10.1021/acsnano.0c02138 · Cited by 97
Phosphorylation modifies the molecular stability of β-amyloid deposits
Rezaei‐Ghaleh, N., Amininasab, M., Kumar, S., Walter, J., & Zweckstetter, M. (2016) · Nature Communications · doi:10.1038/ncomms11359 · Cited by 107
Crippa, V., Cicardi, M. E., Ramesh, N., Seguin, S. J., Ganassi, M., Bigi, I., Diacci, C., Zelotti, E., Baratashvili, M., Gregory, J. M., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw232 · Cited by 95
Self-citationThe role of surfaces on amyloid formation
Grigolato, F., & Arosio, P. (2021) · Biophysical Chemistry · doi:10.1016/j.bpc.2020.106533 · Cited by 96
Dada, S. T., Hardenberg, M. C., Toprakcioglu, Z., Mrugalla, L. K., Cali, M. P., McKeon, M. O., Klimont, E., Michaels, T. C. T., Knowles, T. P. J., & Vendruscolo, M. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2208792120 · Cited by 108
Self-citationMeisl, G., Yang, X., Frohm, B., Knowles, T. P. J., & Linse, S. S. (2016) · Scientific Reports · doi:10.1038/srep18728 · Cited by 97
Self-citationQuantifying Nucleation In Vivo Reveals the Physical Basis of Prion-like Phase Behavior
Khan, T., Kandola, T. S., Wu, J., Venkatesan, S., Ketter, E., Lange, J. J., Gama, A. R., Box, A., Unruh, J. R., Cook, M. E., et al. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.06.016 · Cited by 102
“Rather, pathogenicity has been increasingly attributed to nonamyloid assemblies of the same proteins that are metastable with respect to amyloid (Knowles et al., 2014).”
BackgroundNovel properties and applications of chiral inorganic nanostructures
Xiao, L., An, T., Wang, L., Xu, X., & Sun, H. (2019) · Nano Today · doi:10.1016/j.nantod.2019.100824 · Cited by 95
TRIM11 protects against tauopathies and is down-regulated in Alzheimer’s disease
Zhang, Z.-Y., Harischandra, D. S., Wang, R., Ghaisas, S., Zhao, J. Y., McMonagle, T. P., Zhu, G., Lacuarta, K. D., Song, J., Trojanowski, J. Q., et al. (2023) · Science · doi:10.1126/science.add6696 · Cited by 95
Biophysical insight into the anti-amyloidogenic behavior of taurine
Chaturvedi, S. K., Alam, P., Khan, J. M., Siddiqui, M. K., Ponnusamy, K., Subbarao, N., Ahmad, Z., & Khan, R. H. (2015) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2015.06.035 · Cited by 94
Tau and TDP-43 proteinopathies: kindred pathologic cascades and genetic pleiotropy
Chornenkyy, Y., Fardo, D. W., & Nelson, P. T. (2019) · Laboratory Investigation · doi:10.1038/s41374-019-0196-y · Cited by 93
Amyloid plaques beyond Aβ: a survey of the diverse modulators of amyloid aggregation
Stewart, K. L., & Radford, S. E. (2017) · Biophysical Reviews · doi:10.1007/s12551-017-0271-9 · Cited by 102
Why are Functional Amyloids Non-Toxic in Humans?
Jackson, M. P., & Hewitt, E. W. (2017) · Biomolecules · doi:10.3390/biom7040071 · Cited by 113
Stress-Induced Low Complexity RNA Activates Physiological Amyloidogenesis
Wang, M., Tao, X., Jacob, M. D., Bennett, C. A., Ho, J. J. D., Gonzalgo, M. L., Audas, T. E., & Lee, S. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.07.040 · Cited by 97
“In vitro aggregation and kinetic models of amyloidogenesis predict that, once seeded, fibril growth occurs rapidly by propagation of the amyloid fold (Eisenberg and Jucker, 2012; Kelly, 2000; Knowles et al., 2014).”
BackgroundAsthana, S., Mallick, B., Alexandrescu, A. T., & Jha, S. (2018) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2018.02.020 · Cited by 104
Shrestha, U. R., Smith, J. C., & Petridis, L. (2021) · Communications Biology · doi:10.1038/s42003-021-01759-1 · Cited by 97
High-throughput cryo-EM structure determination of amyloids
Lövestam, S., & Scheres, S. H. W. (2022) · Faraday Discussions · doi:10.1039/d2fd00034b · Cited by 96
Rosenman, D. J., Wang, C., & García, A. E. (2015) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.5b09379 · Cited by 98
Ionic Strength Modulation of the Free Energy Landscape of Aβ 40 Peptide Fibril Formation
Abelein, A., Jarvet, J., Barth, A., Gräslund, A., & Danielsson, J. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.6b04511 · Cited by 97
Xu, S., Di, Z., He, Y., Wang, R., Ma, Y., Sun, R., Li, J., Wang, T., Shen, Y., Fang, S., et al. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1429-0 · Cited by 103
Modulation of Amyloid States by Molecular Chaperones
Wentink, A. S., Nussbaum-Krammer, C. I., & Bukau, B. (2019) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a033969 · Cited by 97
“In vitro, the molecular mechanism of protein aggregation into amyloid fibrils has been described as a multistep pathway (Morris et al. 2009; Eichner and Radford 2011; Knowles et al. 2014) initiated by the stochastic or stress-induced conversion of a native protein into a misor unfolded and aggregation-prone state (Che…”
BackgroundAFM-Based Single Molecule Techniques: Unraveling the Amyloid Pathogenic Species
Ruggeri, F. S., Habchi, J., Cerreta, A., & Dietler, G. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666160518141911 · Cited by 98
Kell, D. B., & Pretorius, E. (2016) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2016.08.006 · Cited by 96
Formation of Apoptosis‐Inducing Amyloid Fibrils by Tryptophan
Shaham‐Niv, S., Rehak, P. L., Vuković, L., Adler‐Abramovich, L., Král, P., & Gazit, E. (2016) · Israel Journal of Chemistry · doi:10.1002/ijch.201600076 · Cited by 90
AmyPro: a database of proteins with validated amyloidogenic regions
Váradi, M., Baets, G. D., Vranken, W., Tompa, P., & Pancsa, R. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx950 · Cited by 102
Amyloid-like Structures Formed by Single Amino Acid Self-Assemblies of Cysteine and Methionine
Gour, N., Chandra Kanth, P., Koshti, B., Kshtriya, V., Shah, D., Patel, S., Agrawal-Rajput, R., & Pandey, M. K. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00310 · Cited by 90
Xuan, Q., Jiang, F., Dong, H., Zhang, W., Zhang, F., Ma, T., Zhuang, J., Yu, J., Wang, Y., Shen, H., et al. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202106705 · Cited by 90
Stenvang, M., Dueholm, M. S., Vad, B. S., Seviour, T. W., Zeng, G., Shochat, S. G., Søndergaard, M. T., Christiansen, G., Meyer, R. L., Kjelleberg, S. J., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.739953 · Cited by 91
Protein homeostasis of a metastable subproteome associated with Alzheimer’s disease
Kundra, R., Ciryam, P., Morimoto, R. I., Dobson, C. M., & Vendruscolo, M. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1618417114 · Cited by 92
Self-citationMechanism of amyloid protein aggregation and the role of inhibitors
Linse, S. S. (2019) · Pure and Applied Chemistry · doi:10.1515/pac-2018-1017 · Cited by 99
Wang, X., Nian, Y., Zhang, Z., Chen, Q., Zeng, X., & Hu, B. (2019) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2019.110459 · Cited by 91
ɑ‐Synuclein strains and the variable pathologies of synucleinopathies
Peelaerts, W., & Baekelandt, V. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13595 · Cited by 105
“…stability of ɑ-SYN showed that the concentration at which ɑ-SYN exists exceeds its predicted own limiting concentration (Baldwin et al. 2011; Knowles et al. 2014). ɑ-SYN is therefore said to be kinetically metastable, which prompted the question of how ɑ-SYN remains soluble under…”
BackgroundInfluentialCharalambidis, G., Georgilis, E., Panda, M. K., Anson, C. E., Powell, A. K., Doyle, S., Moss, D., Jochum, T., Horton, P. N., Coles, S. J., et al. (2016) · Nature Communications · doi:10.1038/ncomms12657 · Cited by 89
Outer membrane protein folding from an energy landscape perspective
Schiffrin, B., Brockwell, D. J., & Radford, S. E. (2017) · BMC Biology · doi:10.1186/s12915-017-0464-5 · Cited by 93
Pansieri, J., Josserand, V., Lee, S.-J., Rongier, A., Imbert, D., Sallanon, M. M., Kövari, E., Dane, T. G., Vendrely, C., Chaix‐Pluchery, O., et al. (2019) · Nature Photonics · doi:10.1038/s41566-019-0422-6 · Cited by 94
3D structure determination of amyloid fibrils using solid-state NMR spectroscopy
Loquet, A., Mammeri, N. E., Stanek, J., Berbon, M., Bardiaux, B., Pintacuda, G., & Habenstein, B. (2018) · Methods · doi:10.1016/j.ymeth.2018.03.014 · Cited by 92
Longhena, F., Faustini, G., Spillantini, M. G., & Bellucci, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20010141 · Cited by 93
Kleino, A., Ramia, N. F., Bozkurt, G., Shen, Y., Nailwal, H., Huang, J., Napetschnig, J., Gangloff, M., Chan, F. K.-M., Wu, H., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.09.011 · Cited by 96
The role of water in the primary nucleation of protein amyloid aggregation
Camino, J. D., Gracia, P., & Cremades, N. (2020) · Biophysical Chemistry · doi:10.1016/j.bpc.2020.106520 · Cited by 90
An in vivo platform for identifying inhibitors of protein aggregation
Saunders, J. C., Young, L. M., Mahood, R. A., Jackson, M. P., Revill, C., Foster, R. J., Smith, D. A., Ashcroft, A. E., Brockwell, D. J., & Radford, S. E. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1988 · Cited by 85
The route to protein aggregate superstructures: Particulates and amyloid‐like spherulites
Vetri, V., & Foderà, V. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.07.006 · Cited by 98
Bunce, S. J., Wang, Y., Stewart, K. L., Ashcroft, A. E., Radford, S. E., Hall, C. K., & Wilson, A. J. (2019) · Science Advances · doi:10.1126/sciadv.aav8216 · Cited by 85
Clark, I. A., & Vissel, B. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13181 · Cited by 84
Ciryam, P., Kundra, R., Freer, R., Morimoto, R. I., Dobson, C. M., & Vendruscolo, M. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1516604113 · Cited by 86
Self-citationRecent Progress in Alzheimer’s Disease Research, Part 1: Pathology
Hane, F. T., Lee, B. Y., & Leonenko, Z. (2017) · Journal of Alzheimer’s Disease · doi:10.3233/jad-160882 · Cited by 84
Tursi, S. A., Puligedda, R. D., Szabo, P., Nicastro, L. K., Miller, A. L., Qiu, C. C., Gallucci, S., Relkin, N. R., Buttaro, B. A., Dessain, S. K., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14685-3 · Cited by 89
High-resolution probing of early events in amyloid-β aggregation related to Alzheimer's disease
Sahoo, B. R., Cox, S. J., & Ramamoorthy, A. (2020) · Chemical Communications · doi:10.1039/d0cc01551b · Cited by 87
Ghosh, P., & De, P. (2020) · ACS Applied Bio Materials · doi:10.1021/acsabm.0c01021 · Cited by 85
Druggability of Intrinsically Disordered Proteins
Joshi, P., & Vendruscolo, M. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-20164-1_13 · Cited by 86
“IDPs Are Implicated in Misfolding Diseases Among all the diseases associated with IDPs, great attention has recently been devoted to misfolding diseases (Chiti and Dobson 2006; Dobson 2001; Knowles et al. 2014).”
BackgroundSelf-citationPhase Separation of Epstein-Barr Virus EBNA2 and Its Coactivator EBNALP Controls Gene Expression
Qiu, P., Wang, L., Qin, Z., Wang, J., Zheng, X., Wei, L., Zhang, X., Zhang, X., Liu, C., Li, Z., et al. (2020) · Journal of Virology · doi:10.1128/jvi.01771-19 · Cited by 87
DAXX represents a new type of protein-folding enabler
Huang, L., Agrawal, T., Zhu, G., Yu, S., Tao, L., Lin, J., Marmorstein, R., Shorter, J., & Yang, X. (2021) · Nature · doi:10.1038/s41586-021-03824-5 · Cited by 86
Meisl, G., Yang, X., Dobson, C. M., Linse, S. S., & Knowles, T. P. J. (2017) · Chemical Science · doi:10.1039/c7sc00215g · Cited by 83
Self-citationLomont, J. P., Ostrander, J. S., Ho, J.-J., Petti, M. K., & Zanni, M. T. (2017) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.7b06826 · Cited by 82
Thermodynamic phase diagram of amyloid-β (16–22) peptide
Wang, Y., Bunce, S. J., Radford, S. E., Wilson, A. J., Auer, S., & Hall, C. K. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1819592116 · Cited by 82
Staphylococcus aureus PSMα3 Cross-α Fibril Polymorphism and Determinants of Cytotoxicity
Tayeb-Fligelman, E., Salinas, N., Tabachnikov, O., & Landau, M. (2020) · Structure · doi:10.1016/j.str.2019.12.006 · Cited by 82
Understanding the Role of Protein Glycation in the Amyloid Aggregation Process
Sirangelo, I., & Iannuzzi, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126609 · Cited by 89
Multisite aggregation of p53 and implications for drug rescue
Wang, G., & Fersht, A. R. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1700308114 · Cited by 54
Diphenylalanine as a Reductionist Model for the Mechanistic Characterization of β-Amyloid Modulators
Brahmachari, S., Arnon, Z. A., Frydman‐Marom, A., Gazit, E., & Adler‐Abramovich, L. (2017) · ACS Nano · doi:10.1021/acsnano.7b01662 · Cited by 83
Cellular Protein Aggregates: Formation, Biological Effects, and Ways of Elimination
Wen, J.-H., He, X., Feng, Z.-S., Li, D.-Y., Tang, J., & Liu, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24108593 · Cited by 92
“Many pieces of research prove that protein aggregates can accumulate in corresponding organs, causing symptoms such as inadequate insulin secretion or cardiac failure [5,34].”
BackgroundInfluentialHu, J.-Y., Zhang, D.-L., Liu, X., Li, X.-S., Cheng, X., Chen, J., Du, H., & Liang, Y. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.11.022 · Cited by 82
Nussbaum, R. L. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a024109 · Cited by 91
Ubiquitination in the ERAD Process
Lopata, A., Kniss, A., Löhr, F., Rogov, V. V., & Dötsch, V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155369 · Cited by 88
Non-specificity as the sticky problem in therapeutic antibody development
Ausserwöger, H., Schneider, M. M., Herling, T. W., Arosio, P., Invernizzi, G., Knowles, T. P. J., & Lorenzen, N. (2022) · Nature Reviews Chemistry · doi:10.1038/s41570-022-00438-x · Cited by 92
Self-citationAleksis, R., Oleskovs, F., Jaudzems, K., Pahnke, J., & Biverstål, H. (2017) · Biochimie · doi:10.1016/j.biochi.2017.07.011 · Cited by 93
Measurement of Tau Filament Fragmentation Provides Insights into Prion-like Spreading
Kundel, F., Hong, L., Falcon, B., McEwan, W. A., Michaels, T. C. T., Meisl, G., Esteras, N., Abramov, A. Y., Knowles, T. J. P., Goedert, M., et al. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00094 · Cited by 83
Self-citationThX – a next-generation probe for the early detection of amyloid aggregates
Needham, L.-M., Weber, J., Varela, J. A., Fyfe, J. W. B., Do, D. T., Xu, C. K., Tutton, L., Cliffe, R., Keenlyside, B., Klenerman, D., et al. (2020) · Chemical Science · doi:10.1039/c9sc04730a · Cited by 87
Self-citationRuggeri, F. S., Habchi, J., Chia, S., Horne, R. I., Vendruscolo, M., & Knowles, T. P. J. (2021) · Nature Communications · doi:10.1038/s41467-020-20782-0 · Cited by 89
Self-citationNew insight into the structure and function of Hfq C-terminus
Fortas, E., Piccirilli, F., Malabirade, A., Militello, V., Trépout, S., Marco, S., Taghbalout, A., & Arluison, V. (2015) · Bioscience Reports · doi:10.1042/bsr20140128 · Cited by 85
Prediction of Peptide and Protein Propensity for Amyloid Formation
Família, C., Dennison, S. R., Quintas, A., & Phoenix, D. A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134679 · Cited by 91
Ultrasensitive Measurement of Ca2+ Influx into Lipid Vesicles Induced by Protein Aggregates
Flagmeier, P., De, S., Wirthensohn, D. C., Lee, S. F., Vincke, C., Muyldermans, S., Knowles, T. P. J., Gandhi, S., Dobson, C. M., & Klenerman, D. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201700966 · Cited by 80
Self-citationHan, X., Jing, Z., Wu, W., Zou, B., Peng, Z., Ren, P. Y., Wikramanayake, A. H., Zhong-min, L., & Leblanc, R. M. (2017) · Nanoscale · doi:10.1039/c7nr04352j · Cited by 84
Shaham‐Niv, S., Rehak, P. L., Zaguri, D., Levin, A., Adler‐Abramovich, L., Vuković, L., Král, P., & Gazit, E. (2018) · Communications Chemistry · doi:10.1038/s42004-018-0025-z · Cited by 79
Ralvenius, W. T., Andresen, J. L., Huston, M. M., Penney, J., Bonner, J. M., Fenton, O. S., Langer, R., & Tsai, L. (2024) · Advanced Materials · doi:10.1002/adma.202309225 · Cited by 78
Self‐Assembled Nanomedicines for Anticancer and Antibacterial Applications
Zhou, L., Qiu, T. A., Lv, F., Liu, L., Ying, J., & Wang, S. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201800670 · Cited by 80
Huang, C., Wagner-Valladolid, S., Stephens, A. D., Jung, R., Poudel, C., Sinnige, T., Lechler, M. C., Schlörit, N., Lu, M., Laine, R. F., et al. (2019) · eLife · doi:10.7554/elife.43059 · Cited by 78
“Indeed, diseaseassociated pre-fibrillar species or oligomers can be highly toxic by interacting through their hydrophobic side chains with other cellular components and in particular lipid membranes (Fusco et al., 2017; Knowles et al., 2014; Walsh et al., 2002).”
BackgroundSelf-citationAlzheimer's amyloid-beta intermediates generated using polymer-nanodiscs
Sahoo, B. R., Genjo, T., Bekier, M. E., Cox, S. J., Stoddard, A. K., Ivanova, M. I., Yasuhara, K., Fierke, C. A., Wang, Y., & Ramamoorthy, A. (2018) · Chemical Communications · doi:10.1039/c8cc07921h · Cited by 82
Amyloid-Beta Peptides Trigger Aggregation of Alpha-Synuclein In Vitro
Köppen, J., Schulze, A., Machner, L., Wermann, M., Eichentopf, R., Guthardt, M., Hähnel, A., Klehm, J., Kriegeskorte, M.-C., Hartlage‐Rübsamen, M., et al. (2020) · Molecules · doi:10.3390/molecules25030580 · Cited by 82
The Hsc70 disaggregation machinery removes monomer units directly from α-synuclein fibril ends
Schneider, M. M., Gautam, S., Herling, T. W., Andrzejewska, E., Krainer, G., Miller, A., Trinkaus, V. A., Peter, Q. A. E., Ruggeri, F. S., Vendruscolo, M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25966-w · Cited by 80
Self-citationHu, R., Diao, J., Li, J., Tang, Z., Li, X., Leitz, J., Long, J., Liu, J., Yu, D., & Zhao, Q. (2016) · Scientific Reports · doi:10.1038/srep20776 · Cited by 87
Kurnik, M., Sahin, C., Andersen, C. B., Lorenzen, N., Giehm, L., Mohammad‐Beigi, H., Jessen, C. M., Pedersen, J. S., Christiansen, G., Petersen, S. V., et al. (2018) · Cell chemical biology · doi:10.1016/j.chembiol.2018.08.005 · Cited by 82
Shaham‐Niv, S., Arnon, Z. A., Sade, D., Lichtenstein, A., Shirshin, E. A., Kolusheva, S., & Gazit, E. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201806565 · Cited by 77
Tuning the rate of aggregation of hIAPP into amyloid using small-molecule modulators of assembly
Xu, Y., Maya‐Martinez, R., Guthertz, N., Heath, G. R., Manfield, I. W., Breeze, A. L., Sobott, F., Foster, R., & Radford, S. E. (2022) · Nature Communications · doi:10.1038/s41467-022-28660-7 · Cited by 83
“We performed the Aβ42 assays under two conditions: (1) conditions which have previously been reported to generate highly reproducible aggregation kinetics of Aβ42 and have been used widely to determine the effect of small molecules on Aβ42 aggregation70; (2) identical conditions to those used here to monitor the aggre…”
Jördens, S., Rühs, P. A., Sieber, C., Isa, L., Fischer, P., & Mezzenga, R. (2014) · Langmuir · doi:10.1021/la5020658 · Cited by 77
Metadata
- Authors
- Knowles, T. P. J., Vendruscolo, M., & Dobson, C. M.
- Affiliations
- University of Cambridge (GB)
- Corresponding author
- Knowles, Tuomas P. J.
- Vendruscolo, Michele
- Dobson, Christopher M.
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2014-05-23
- Volume
- 15
- Issue
- 6
- Pages
- 384-396
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- OpenAlex
- W1970577444
- Cited by
- 2,382
- References
- 184
- Citations by year
- 2026: 148 · 2025: 150 · 2024: 191 · 2023: 168 · 2022: 186 · 2021: 205 · 2020: 269 · 2019: 230 · 2018: 253 · 2017: 215 · 2016: 184 · 2015: 152 · 2014: 30
- FWCI
- 22.79
- Type
- journal article
- Language
- en
- Update notices
- erratum (2014-06-12)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Frances and Augustus Newman Foundation
- Biotechnology and Biological Sciences Research Council (BB/H003843/1, BB/J002119/1)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Keywords
- amyloid, protein misfolding, protein aggregation, amyloid deposition, proteostasis, Alzheimer's disease, type 2 diabetes, amyloidosis
- MeSH terms
- Alzheimer Disease, Amyloid, Amyloidosis, Animals, Humans, Protein Conformation, Protein Folding
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.